Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Signature Scents: A Manual for Outstanding Fragrances - 2Vote In favor of Your Favored Shimmering Water
- 3What's going on with Katseye? The Manon Bannerman hiatus drama, explained.
- 4This Miraculous, Cliff-Perched Town In The South Of France Is A Sacred European Gem
- 5Huge solar flare no threat to Artemis 2 astronaut launch to the moon, NASA says
- Figurine of a woman and a goose offers peek at prehistoric beliefs
- Step by step instructions to Involve Compact disc Rates for Magnanimous Giving
- Employers and staff feel effect of fuel price rise
- French rapper Gims placed under investigation for 'aggravated money laundering'
- 'The Boys' Season 5 premiere: How to watch for less, what to know about the final series and more
- When preventable infections turn deadly behind bars | The Excerpt
- Germany records first wolf bite on human since repopulation
- Taylor Momsen explains why she quit 'Gossip Girl': 'I really didn't want to be there'
- Home Plan Tips for Seniors
